Diabetes & Metabolism

Papers
(The H4-Index of Diabetes & Metabolism is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Variable incidence of ketoacidosis in youth with type 1 diabetes onset during COVID-19 pandemic peaks in France69
Glycemic Risk Index (GRI) variability in type 1 diabetes adults with HbA1c ≤ 7%: Insights for clinical evaluation and intervention64
Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach60
Comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in preventing Alzheimer's disease, vascular dementia, and other dementia types among patients with type 2 diabetes56
Insulin pump initiation in outpatient settings: When technology facilitates new healthcare organizations43
Elevation of hemoglobin A1c increases the risk of decline in left ventricular systolic function among patients with coronary artery disease34
Impact of BMI on prevalence of coronary atherosclerotic lesions in non-smoking premenopausal diabetic women: A monocentric study34
Prevention of exercise-induced hypoglycemia in 12 patients with type 1 diabetes running the Paris Marathon using continuous glucose monitoring: A prospective, single-center observational study34
Discontinuation of hemodialysis after correction of a major hypothyroidism episode, A case report33
Association between diabetes and stress-induced hyperglycemia with skeletal muscle gene expression of INSR in critically ill patients: A prospective cohort study33
Editorial board31
Analysis of glycemic control in diabetic patients by monitoring HbA1c levels before, during and after Covid-19 confinement in Auvergne, France30
Pancreas allograft rejection occurring after ChAdOx1 nCoV-19 vaccine29
Residual risk associations between initial hyperglycemia and adverse pregnancy outcomes in a large cohort including 6709 women with gestational diabetes27
Contents - page 127
Prognosis associated with initial care of increased fasting glucose in early pregnancy: A retrospective study27
Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: A prospective cohort study25
Effect of high-dose mineralocorticoid receptor antagonist eplerenone on urinary albumin excretion in patients with type 2 diabetes and high cardiovascular risk: Data from the MIRAD trial25
Compared impact of diabetes on the risk of heart failure from acute myocardial infarction to chronic coronary artery disease25
The association between metformin treatment and COVID-19 outcomes according to metformin continuation during hospitalisation25
Increased risk of renal events in people with diabetic foot disease: A longitudinal observational study25
SGLT2 inhibitors and the autonomic nervous system in diabetes: A promising challenge to better understand multiple target improvement24
Cost analysis of continuous glucose monitoring in patients hospitalized in a diabetes department24
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies24
0.034546852111816